Fabhalta 200 MG
Ended Awarded
- Contract number
- 36C24526N0113
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $33,838
Award facts
- Contract value 100% obligated
- $33,838.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cary, NC 27513, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a delivery order valued at $33.8K to Novartis Pharmaceuticals Corporation for the supply of FABHALTA 200 mg, a pharmaceutical product. The contract was awarded on October 21, 2025, with a completion date of October 24, 2025, and utilizes firm fixed-price pricing under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Performance of this delivery order will take place in Cary, North Carolina. No small business set-aside was applied to this award, indicating the contract was competed in the open market.
This delivery order is issued under Novartis' existing Federal Supply Schedule contract, enabling the VA to procure specialized pharmaceutical products through its established relationship with the company. Novartis, a foreign-owned pharmaceutical manufacturer headquartered in East Hanover, New Jersey, maintains significant federal contracts with the VA and Defense Health Agency focused primarily on cancer therapies and specialized medical treatments. The company's federal contracting activity demonstrates extensive experience supplying innovative medical products to support veteran healthcare initiatives and other federal healthcare systems.
Quick answers
Who was awarded contract 36C24526N0113?
36C24526N0113 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 21, 2025.
How much is contract 36C24526N0113 worth?
The government has obligated $33,838 on 36C24526N0113.
Is contract 36C24526N0113 an order under another contract?
Yes. 36C24526N0113 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0113 competed?
The extent of competition for 36C24526N0113 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award